Neurology and the lupus anticoagulant

Area of Science:

• Immunology
• Hematology
• Neurology

Background:

• The lupus anticoagulant is an immunoglobulin (IgG or IgM) belonging to the antiphospholipid antibody group.
• While functioning as an anticoagulant in laboratory tests (in vitro), it acts as a procoagulant in the body (in vivo).

Purpose of the Study:

• To highlight the procoagulant role of the lupus anticoagulant in vivo.
• To discuss its potential involvement in various organ systems, particularly the nervous system.
• To emphasize its significance as a potential, though uncommon, cause of neurological diseases.

Main Methods:

• Review of existing literature and case studies associating lupus anticoagulant with neurological events.
• Analysis of the procoagulant mechanisms of lupus anticoagulant.
• Clinical correlation of laboratory findings (prolonged coagulation pathways, thrombosis) with neurological manifestations.

Main Results:

• The lupus anticoagulant's in vivo procoagulant activity can affect multiple organ systems.
• Specific neurological conditions linked to lupus anticoagulant include cerebral thrombosis, spinal thrombosis, chorea, and Guillain-Barré syndrome.
• Association with prolonged coagulation pathways and other autoimmune phenomena is noted.

Conclusions:

• The lupus anticoagulant, despite its in vitro anticoagulant properties, poses a procoagulant risk in vivo.
• It is an important, albeit uncommon, consideration in the differential diagnosis of neurological diseases, especially when thrombosis and autoimmune markers are present.
• Further investigation into its procoagulant mechanisms and clinical impact is warranted.